scispace - formally typeset
Open AccessJournal ArticleDOI

A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement

Reads0
Chats0
TLDR
A large family with a late-onset phenotype including motor neuron disease, cognitive decline resembling frontotemporal dementia, cerebellar ataxia and myopathy is reported, showing that mitochondrial disease may be at the origin of some of these phenotypes.
Abstract
Mitochondrial DNA instability disorders are responsible for a large clinical spectrum, among which amyotrophic lateral sclerosis-like symptoms and frontotemporal dementia are extremely rare. We report a large family with a late-onset phenotype including motor neuron disease, cognitive decline resembling frontotemporal dementia, cerebellar ataxia and myopathy. In all patients, muscle biopsy showed ragged-red and cytochrome c oxidase-negative fibres with combined respiratory chain deficiency and abnormal assembly of complex V. The multiple mitochondrial DNA deletions found in skeletal muscle revealed a mitochondrial DNA instability disorder. Patient fibroblasts present with respiratory chain deficiency, mitochondrial ultrastructural alterations and fragmentation of the mitochondrial network. Interestingly, expression of matrix-targeted photoactivatable GFP showed that mitochondrial fusion was not inhibited in patient fibroblasts. Using whole-exome sequencing we identified a missense mutation (c.176C>T; p.Ser59Leu) in the CHCHD10 gene that encodes a coiled-coil helix coiled-coil helix protein, whose function is unknown. We show that CHCHD10 is a mitochondrial protein located in the intermembrane space and enriched at cristae junctions. Overexpression of a CHCHD10 mutant allele in HeLa cells led to fragmentation of the mitochondrial network and ultrastructural major abnormalities including loss, disorganization and dilatation of cristae. The observation of a frontotemporal dementia-amyotrophic lateral sclerosis phenotype in a mitochondrial disease led us to analyse CHCHD10 in a cohort of 21 families with pathologically proven frontotemporal dementia-amyotrophic lateral sclerosis. We identified the same missense p.Ser59Leu mutation in one of these families. This work opens a novel field to explore the pathogenesis of the frontotemporal dementia-amyotrophic lateral sclerosis clinical spectrum by showing that mitochondrial disease may be at the origin of some of these phenotypes.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Enfermedades mitocondriales

TL;DR: In this paper , aparición de la secuenciación de alto rendimiento ha modificado por completo el proceso diagnóstico and ha mejorado en gran medida the identificación of los genes implicados en las enfermedades mitocondriales.
Book ChapterDOI

Mendelian and sporadic FTD: disease risk and avenues from genetics to disease pathways through in silico modelling.

TL;DR: In this paper, the authors focus on the heterogeneous features of FTD touching upon its complex genetic landscape and discuss how novel approaches (e.g., computationally driven systems biology) promise to revolutionise the translation of genetic information into functional understanding of disease pathogenesis.
Journal ArticleDOI

Loss of mitochondrial Chchd10 or Chchd2 in zebrafish leads to an ALS‐like phenotype and Complex I deficiency independent of the mitochondrial integrated stress response

TL;DR: In this paper , the authors investigated the role of chchd10 and CHCHD2 in vertebrate development using knockout (KO) models in zebrafish and showed that loss of either or both proteins leads to motor impairment, reduced survival and compromised neuromuscular junction integrity.
Journal ArticleDOI

Protein interaction network analysis reveals genetic enrichment of immune system genes in frontotemporal dementia

TL;DR: In this paper , the authors applied protein interaction network (PIN) analysis to prioritize candidate genes for rare variant association analysis and presented a computational pipeline for identifying potential novel therapeutic targets and risk-modifying variants.
Posted ContentDOI

Dominant toxicity of ALS-FTD-associated CHCHD10S59L is mediated by TDP-43 and PINK1

TL;DR: Findings indicate that TDP-43 mitochondrial translocation and chronic activation of PINK1-mediated pathways by CHCHD10S59L generate dominant toxicity, and inhibiting Pink1 activity may provide a therapeutic strategy for CHCHd10-associated disease.
References
More filters
Journal ArticleDOI

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

TL;DR: This assay is very reproducible and rapid with the dye binding process virtually complete in approximately 2 min with good color stability for 1 hr with little or no interference from cations such as sodium or potassium nor from carbohydrates such as sucrose.
Journal ArticleDOI

Protein structure prediction on the Web: a case study using the Phyre server.

TL;DR: This protocol provides a guide to interpreting the output of structure prediction servers in general and one such tool in particular, the protein homology/analogy recognition engine (Phyre), which can reliably detect up to twice as many remote homologies as standard sequence-profile searching.
Journal ArticleDOI

A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD

Alan E. Renton, +85 more
- 20 Oct 2011 - 
TL;DR: The chromosome 9p21 amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD) locus contains one of the last major unidentified autosomal-dominant genes underlying these common neurodegenerative diseases, and a large hexanucleotide repeat expansion in the first intron of C9ORF72 is shown.
Related Papers (5)

A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD

Alan E. Renton, +85 more
- 20 Oct 2011 - 

Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways

Elizabeth T. Cirulli, +70 more
- 27 Mar 2015 -